Search - tctmd.com

Displaying 21 - 40 of 149

Sort: Relevancy | Date

Study Supports Cost-effectiveness of Renal Denervation for Hypertension

News Daily News

Study Supports Cost-effectiveness of Renal Denervation for Hypertension

August 23, 2024

Statins Effective For Primary Prevention in Old and Very Old

News Daily News

Statins Effective For Primary Prevention in Old and Very Old

Michael O'Riordan

May 29, 2024

Holistic Screening for Preeclampsia in First Trimester Bests Clinical Factors Alone

News Daily News

Holistic Screening for Preeclampsia in First Trimester Bests Clinical Factors Alone

May 20, 2024

TARGET BP 1: Alcohol-Based RDN Promises Single Treatment for Resistant BP

News Conference News ACC 2024

TARGET BP 1: Alcohol-Based RDN Promises Single Treatment for Resistant BP

April 16, 2024

PREVENT Supports Early PCI for Vulnerable Plaque, With Reductions in MACE

News Conference News ACC 2024

PREVENT Supports Early PCI for Vulnerable Plaque, With Reductions in MACE

April 08, 2024

TLR Rates Rise Steadily After Left Main PCI, but Deaths Stay Stable

News Daily News

TLR Rates Rise Steadily After Left Main PCI, but Deaths Stay Stable

Michael O'Riordan

January 09, 2024

Top Endovascular News of 2023

News Daily News

Top Endovascular News of 2023

December 28, 2023

Aspirin Use Tied to Slower AAA Progression

News Daily News

Aspirin Use Tied to Slower AAA Progression

December 20, 2023

Turning Back Subclinical Atherosclerosis Possible in Some Middle-Age People

News Daily News

Turning Back Subclinical Atherosclerosis Possible in Some Middle-Age People

November 22, 2023

Symplicity Spyral Approved: FDA Clears Second Renal Denervation System

News Daily News

Symplicity Spyral Approved: FDA Clears Second Renal Denervation System

November 20, 2023

FDA Approves Paradise Renal Denervation System: What Comes Next?

News Daily News

FDA Approves Paradise Renal Denervation System: What Comes Next?

November 08, 2023

RADIANCE Modest Renal Denervation Effect Remains at 6 Months

News Conference News TCT 2023

RADIANCE: 'Modest' Renal Denervation Effect Remains at 6 Months

October 31, 2023

TCT 325: Changes in Blood Pressure after Crossover to Ultrasound Renal Denervation: Patient-Level Pooled Analysis of the Sham-Controlled RADIANCE II, RADIANCE-HTN SOLO and RADIANCE-HTN TRIO Trials

Presentation TCT 2023

TCT 325: Changes in Blood Pressure after Crossover to Ultrasound Renal Denervation: Patient-Level Pooled Analysis of the Sham-Controlled RADIANCE II, RADIANCE-HTN SOLO and RADIANCE-HTN TRIO Trials

Presenter: Michael Bloch

October 25, 2023

Hypertension Care Pathway with uRDN: Experiences from Clinical Trials

Presentation TCT 2023

Hypertension Care Pathway with uRDN: Experiences from Clinical Trials

Presenter: NULL

October 25, 2023

A High Standard of Clinical Evidence: Recent Key Milestones

Presentation TCT 2023

A High Standard of Clinical Evidence: Recent Key Milestones

Presenter: NULL

October 25, 2023

TCT 635: Performance of Near-Infrared Spectroscopy-Intravascular Ultrasound and Optical Coherence Tomography for Coronary Artery Plaque Structural Stress Analysis: Validation Against Histology

Presentation TCT 2023

TCT 635: Performance of Near-Infrared Spectroscopy-Intravascular Ultrasound and Optical Coherence Tomography for Coronary Artery Plaque Structural Stress Analysis: Validation Against Histology

Presenter: Retesh Bajaj

October 25, 2023

TCT 398: Endovascular Ultrasound Renal Denervation to Treat Uncontrolled Hypertension: Six-Month Results Following Blinded Medication Titration in the Randomized, Sham-Controlled RADIANCE II Pivotal Trial

Presentation TCT 2023

TCT 398: Endovascular Ultrasound Renal Denervation to Treat Uncontrolled Hypertension: Six-Month Results Following Blinded Medication Titration in the Randomized, Sham-Controlled RADIANCE II Pivotal Trial

Presenter: Michel Azizi

October 25, 2023

TCT 210: Long-term Safety and Efficacy of Endovascular Ultrasound Renal Denervation in Resistant Hypertension: 8-year results from the ACHIEVE study

Presentation TCT 2023

TCT 210: Long-term Safety and Efficacy of Endovascular Ultrasound Renal Denervation in Resistant Hypertension: 8-year results from the ACHIEVE study

Presenter: Victor Zeijen

October 25, 2023

Medtronic’s Renal Denervation System Fails to Sway FDA Advisory Panel

News Daily News

Medtronic’s Renal Denervation System Fails to Sway FDA Advisory Panel

August 23, 2023

ReCor’s Renal Denervation System Gets Thumbs Up From FDA Advisory Panel

News Daily News

ReCor’s Renal Denervation System Gets Thumbs Up From FDA Advisory Panel

August 22, 2023

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.